<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01914952</url>
  </required_header>
  <id_info>
    <org_study_id>MTI2013-CS02</org_study_id>
    <nct_id>NCT01914952</nct_id>
  </id_info>
  <brief_title>Alternate Dosing Strategies for Beta-hydroxy-beta-methylbutyrate (HMB) Supplementation: Effect on Plasma HMB Responses</brief_title>
  <official_title>Alternate Dosing Strategies for Beta-hydroxy-beta-methylbutyrate (HMB) Supplementation: Effect on Plasma HMB Responses</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Metabolic Technologies Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Metabolic Technologies Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to examine the rise in plasma Beta-hydroxy-beta-methylbutyrate&#xD;
      (HMB) after the dietary supplement has been administered in different forms. Prior studies&#xD;
      have indicated that form of administration affects bioavailability of the HMB supplement.&#xD;
      Therefore the current study will examine the bioavailability of a single dose of HMB given&#xD;
      as:&#xD;
&#xD;
        -  1.0g CaHMB in gelatin capsule&#xD;
&#xD;
        -  0.8 g HMB free acid in a gelcap&#xD;
&#xD;
        -  0.8 g HMB free acid in water&#xD;
&#xD;
        -  1.0 g CaHMB in water&#xD;
&#xD;
        -  0.8 g HMB free acid&#xD;
&#xD;
      The randomized study will be a crossover design and each study subject will undergo the&#xD;
      experimental protocol for each of the supplementation forms. Because of the different&#xD;
      administration forms, the study will be an open label study. Briefly, the fasted participants&#xD;
      will report to the laboratory in the morning. After an initial blood sample is taken, the&#xD;
      dose of HMB will be administered. Blood will then be samples at 2, 5, 10, 15, 25, 35, 45, 60,&#xD;
      90, 120, 180, 360, 720, and 1440 min post administration. A 24 h complete urine collection&#xD;
      will also be performed. Participants will be given a light sack lunch 4 h after&#xD;
      administration of the dosage and will remain at the laboratory through the 360 min sampling.&#xD;
      Participants will then be allowed to leave the laboratory and return for the 720 min sampling&#xD;
      after which the participants can eat an normal evening meal. Participants will return to the&#xD;
      laboratory fasted the next morning for the final sample. A minimum 48 h washout period will&#xD;
      be required before the next dosage form is administered and the process repeated.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2013</start_date>
  <completion_date type="Actual">May 2014</completion_date>
  <primary_completion_date type="Actual">May 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Plasma HMB Level</measure>
    <time_frame>Plasma samples collected at 0, 2, 5, 10, 15, 25, 35, 45, 60, 90, 120, 180, 360, 720, and 1440 min after treatment administration</time_frame>
  </primary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Actual">11</enrollment>
  <condition>Focus of the Study is to Examine Plasma HMB Levels After Oral HMB Supplementation</condition>
  <arm_group>
    <arm_group_label>CaHMB Capsule</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>HMB free acid gelcap</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>HMB free acid in water</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>CaHMB powder in water</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>HMB free acid (oral not in gelcap or water)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>CaHMB capsule</intervention_name>
    <description>1.0 gram of CaHMB powder in a gelatin capsule</description>
    <arm_group_label>CaHMB Capsule</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>HMB free acid gelcap</intervention_name>
    <description>0.8 g HMB free acid is a soft gel capsule</description>
    <arm_group_label>HMB free acid gelcap</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>HMB free acid mixed in water</intervention_name>
    <description>0.8 g HMB free acid in water</description>
    <arm_group_label>HMB free acid in water</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>CaHMB in water</intervention_name>
    <description>1.0 g CaHMB powder mixed in water</description>
    <arm_group_label>CaHMB powder in water</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>HMB free acid</intervention_name>
    <description>0.8 g HMB free acid</description>
    <arm_group_label>HMB free acid (oral not in gelcap or water)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Must not be taking amino acid, protein, or HMB supplements; Must not be pregnant; Must&#xD;
             not be breastfeeding&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Currently taking amino acid, protein, or HMB supplements; Currently pregnant;&#xD;
             Currently breastfeeding&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>30 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Iowa State University</name>
      <address>
        <city>Ames</city>
        <state>Iowa</state>
        <zip>50014</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2014</verification_date>
  <study_first_submitted>July 31, 2013</study_first_submitted>
  <study_first_submitted_qc>August 1, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 2, 2013</study_first_posted>
  <last_update_submitted>September 15, 2014</last_update_submitted>
  <last_update_submitted_qc>September 15, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 16, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>CaHMB</keyword>
  <keyword>HMB free acid</keyword>
  <keyword>HMB</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

